Topical administration of in situ gelling formulation containing myricetin-polycarboxylate nanoparticles inhibits murine genital herpes infection. - Mallick S; Sharma P; Yadavalli T; Koganti R; Singh SK; Yoshimura K; Kapoor D; Sutar Y; Adams JS; Annaji M; Shukla D; Date AA (International journal of pharmaceutics, 2026)